Back

Enhancing patient experience in clinical trials

Request Number N185690
Need details
Description

Clinical trials are required whenever GSK develops a new medicine. Patients are central to any clinical trial and every new medicine that GSK works on – we are always looking at ways in which GSK can improve the experience of patients taking part in clinical trials. GSK views patients as partners in every clinical trial and wants to explore ways of enhancing this partnership using new technologies and methodologies.

 

 

Background

By their nature, clinical trials require patients to attend visits with their care team and generally have additional assessments on top of their normal appointments. GSK are looking to understand how we can minimise the burden of the clinical trial process for patients and enhance the patient experience of taking part in a clinical trial. In addition to minimising burden, GSK also wants to consider ways in which the clinical trial experience can be improved so that it is more engaging for patients – they can feel more a part of a larger research initiative than an individual. This should happen while the study adheres to the principles of Good Clinical Practice and other relevant regulations and guidelines.

 

Successful applicants with viable proposals with sufficient experience in the clinic will be invited to present their proposal to a group within GSK. Subsequently, if the idea is sufficiently mature with experience in clinical, there may be opportunities to scope a prototype within GSK and even to pilot the innovation within a GSK clinical study.

 

Key Success Criteria
  • Approaches that improve the experience of patients taking part in clinical trials
  • The ideas should be compatible with Good Clinical Practice and other regulatory and legal requirements for clinical research 

 

Approaches not of interest
All proposals that meet the key success criteria will be considered.
Preferred Collaboration types
  • To Be Negotiated
Items to be submitted
  • A non-confidential proposal describing the solution and how the success criteria will be met with the proposed solution
  • non-confidential description of the technology
  • An overview of your experience with digital tools and/or clinical trials

 

Point of Contact
Stephen Clulow
Area of Interest
  • Education & Training
  • Medical Products & Services
  • Pharmaceuticals
  • Nutriceuticals
  • Therapeutics
  • Biologics
  • Pharmaceutical R & D
  • Biopharmaceuticals
  • Other
  • Professional Services
  • Research Organizations
Organization
GSK
Due Date
March 23, 2018
Attachments
This page does not have file attachments.
This page does not have file attachments.
Comments